BioAtla PE Ratio 2020-2021 | BCAB
Current and historical p/e ratio for BioAtla (BCAB) from 2020 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BioAtla PE ratio as of September 24, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|BioAtla PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.